Jennison Associates LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Jennison Associates LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 11, 2021	SELL	$74.73 - $90.69 $3.74 Million - $4.53 Million	-50,000 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$72.61 - $90.2 $726,100 - $902,000	-10,000 Reduced 16.67%	50,000 $4.39 Million
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $3.86 Million - $5.18 Million	60,000 New	60,000 $5.07 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.